Importantly, the success of FAK inhibition in the present study highlights the translational potential of establishing FAK as a target for ESCC treatment in the setting of crosstalk between tumor cells and the TME (Fig. 8). Here, PTK2 is linked to esophageal squamous cell carcinoma.